MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms

Saved in:

Bibliographic Details
Published in:	Leukemia Vol. 24; no. 4; pp. 859 - 860
Main Authors:	Patnaik, M M, Lasho, T L, Finke, C M, Gangat, N, Caramazza, D, Siragusa, S, Hanson, C A, Pardanani, A, Tefferi, A
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-04-2010 Nature Publishing Group
Subjects:	631/208/205 631/208/728 692/699/67/1990/2331 Biological and medical sciences Cancer Research Critical Care Medicine Female Gene mutations Genetic aspects Genotype Haplotypes Haplotypes - genetics Health aspects Hematologic and hematopoietic diseases Hematology Humans Intensive Internal Medicine Janus kinase 2 Janus Kinase 2 - genetics letter-to-the-editor Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Medicine Medicine & Public Health Middle Aged Mutation Mutation - genetics Myeloproliferative disorders Myeloproliferative Disorders - genetics Myeloproliferative Disorders - pathology Neoplasms Oncology Physiological aspects Polymerase Chain Reaction Polymorphism, Single Nucleotide - genetics Protein tyrosine kinase Receptors, Thrombopoietin - genetics Risk factors United States Thrombopoietin receptor Hematology Enzyme JAK2 protein tyrosine kinase Transferases Hemopathy Myeloproliferative syndrome Growth factor receptor C-Onc gene Frequency Genetics Mutation Haplotype Protein-tyrosine kinase Protooncogene
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1
ISSN:	0887-6924 1476-5551
DOI:	10.1038/leu.2010.1